Trial reportFrontiers in public health2025
Effect of Baduanjin exercise on sarcopenia in older adult patients: a multicenter, randomized controlled trial.
Trial report in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sarcopenia is an age-related syndrome characterized by muscle loss and reduced muscle strength, with a high incidence rate, significantly increasing the risk of falls, fractures, and death. Baduanjin, a traditional Chinese exercise, compared with traditional rehabilitation programs, has low intensity, high safety and strong interest, and is particularly suitable for patients who cannot tolerate high-intensity exercise. This study will evaluate the therapeutic effect of Baduanjin on sarcopenia. Method/design: This trial is a multicenter randomized controlled trial that will recruit 200 participants,and is randomized (1: 1) the subjects to the intervention group (Baduanjin + health education + dietary guidance, BHD) and the control group (health education + dietary guidance, HD). After enrollment, health lectures were given to all subjects. The intervention group received 12 weeks of Baduanjin intervention, with each class lasting 70 min, once a week, and provide online guidance for home workouts four times a week, while the control group maintained their original exercise habits. Health education and dietary guidance were also provided. Observation indicators will be tested before the trial begins and during the follow-up period after the intervention ends. Discussion: This trial is a randomized controlled trial that will evaluate the intervention effect of Baduanjin on sarcopenia. According to the study of this trial, it will provide evidence for Baduanjin to improve sarcopenia. Clinical trial registration: ITMCTR2024000887.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.